Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - NET INCOME
Net Income URGN - UroGen Pharma Ltd.
-102 M
LAST VALUE
3.95%
2 YEAR CAGR
-6.21%
5 YEAR CAGR
-40.94%
10 YEAR CAGR